Pharming Group NV stock reached a significant milestone, hitting a 52-week high at 17.89 USD. According to InvestingPro data, the stock is currently trading at 17.94 USD, slightly above this recent ...

Leiden, the Netherlands, December 8, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the Oppenheimer Movers in Rare Disease Summit ...

U.S. stocks were mixed, with the Dow Jones index gaining more than 300 points on Wednesday. Shares of Pharming Group N.V. (NASDAQ:PHAR) rose sharply during Wednesday's session after the company ...

Pharming Group N.V. (NASDAQ:PHAR) Q3 2025 Earnings Call Transcript November 6, 2025 Pharming Group N.V. beats earnings expectations. Reported EPS is $0.1, expectations were $0.05. Operator: Good day, ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Pharming Group ( ...

Leiden, the Netherlands, September 10, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that it has been promoted from the Euronext AScX® (Small ...

A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now help physicians more quickly diagnose patients with suspected genetic ...

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, ...